All In MedTech

Device Trial Radar · NCT07945483

Effects of Bubble-PEP After Open Heart Surgery on Blood Gases, Dyspnea, Secretion Status, and Pain

The Effect of Bubble-PEP Intervention After Open Heart Surgery on Arterial Blood Gas, Dyspnea, Secretion Status, and Pain: A Randomized Controlled Study

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

92

Planned (sponsor's estimate)

Start

Nov 16, 2026

Primary completion

Apr 1, 2027

Study completion Aug 30, 2027

Sponsor

Lead sponsor
Afyonkarahisar Health Sciences UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled study aims to evaluate the effects of Bubble Positive Expiratory Pressure (Bubble-PEP) therapy on arterial blood gas parameters, dyspnea, respiratory secretion status, and pain in patients undergoing open-heart surgery. The study will be conducted in the Cardiovascular Surgery Department and Intensive Care Unit of Afyonkarahisar Health Sciences University Health Research and Application Center, Türkiye. A total of 92 adult patients undergoing coronary artery bypass grafting or heart valve surgery will be included. Participants will be randomly assigned to an intervention group (n=46) or a control group (n=46) using stratified block randomization based on surgical procedure. Both groups will receive standard postoperative care, including breathing exercises, chest percussion, and incentive spirometry. In addition to standard care, the intervention group will receive Bubble-PEP therapy twice daily for three consecutive days following extubation. Each session will consist of three sets of 10 expirations. Arterial blood gas parameters, dyspnea, respiratory secretion status, and pain will be assessed at baseline, during follow-up, and after completion of the intervention. Patient satisfaction will also be evaluated. The study aims to determine whether adding Bubble-PEP therapy to standard postoperative care improves respiratory outcomes and contributes to evidence-based nursing care following open-heart surgery.

Conditions

  • Cardiac Surgery
  • Open Heart Surgery

Interventions

  • Bubble Positive Expiratory Pressure (Bubble-PEP) TherapyDevice

    A researcher-prepared Bubble Positive Expiratory Pressure (Bubble-PEP) device will be used in addition to standard postoperative care. The device will consist of a 1.5-liter plastic bottle filled with water to a depth of 10 cm and an approximately 80-cm-long tube with an internal diameter of 8 mm. Each patient will be provided with an individual bottle and tube. Bubble-PEP therapy will be initiated after extubation when the patient is conscious, hemodynamically stable, and considered clinically suitable by the treating physician. During the intervention, the patient will be placed in an upright sitting position and instructed to inhale deeply through the nose, followed by slow, controlled, and continuous exhalation through the tube submerged in water. The intervention will be administered twice daily, in the morning and afternoon, on the first, second, and third days after extubation. Each session will consist of three sets of 10 expirations, totaling 30 expirations per session.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Arterial Oxygen Partial Pressure(PaO₂)Time frame: Days 1, 2, and 3 post-extubation
  2. Change in Arterial Carbon Dioxide Partial Pressure(PaCO₂)Time frame: Days 1, 2, and 3 post-extubation
  3. Change in Arterial Blood pHTime frame: Days 1, 2, and 3 post-extubation

5 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Afyonkarahisar University of Health Sciences

    Afyonkarahisar, Centre, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.